首页> 外国专利> Liposomal, gel-like phthalocyanine composition for photodynamic therapy of tumor diseases and process for preparing thereof

Liposomal, gel-like phthalocyanine composition for photodynamic therapy of tumor diseases and process for preparing thereof

机译:用于肿瘤疾病的光动力治疗的脂质体,凝胶状酞菁组合物及其制备方法

摘要

The liposomal gel phthalocyanine preparation for photodynamic therapy of cancer and other diseases is formed by a set of lecithin liposomes with incorporated hydrophobic active agent, selected from the group consisting of hydroxy aluminum, aluminum, zinc, silicon or organosilicate, or hydrophobic metal-free phthalocyanine mixed in a 10: 1 to 1 ratio : 10 with a round pharmacy gel. The added active ingredient can be treated by coating with glucose or other sugars, polyethylene glycol or other polymers, lecithin, or NaCl or other salt suitable for pharmacology. The preparation is that the lecithin at a concentration of 1 to 40 mg per ml of fluid is fluidized in a microfluidizer in the appropriate chamber to a final particle size of less than 1000 nm at a temperature greater than 0 degC and a pressure of 50-200 MPa, followed by continuous mixing adds the active ingredient or the treated active ingredient in a ratio of between 5: 1 to 0.1: 1 in relation to lecithin, the resulting suspension being repeatedly fluidized on the microfluidizer in the respective smaller chamber to a final particle size of less than 500 nanometers at a pressure of 100 to 200 MPa at a temperature greater than 0 degC, the suspension obtained is then mixed with a circulating pharmaceutical gel in ratios of between 10: 1 to 1:10. Optionally, the lecithin is fluidized separately and the active agent also separately in the first step above, or the lecithin is processed by extrusion through 50-100 nm filters. The resulting suspension is then mixed with a circulating drug gel in a ratio of between 10: 1 to 1:10. The resulting liposome-containing gel with the incorporated active ingredient is applied to the topical tumors in dermatology or other tumors available to the light-guide light-guide in therapy.
机译:用于光动力疗法治疗癌症和其他疾病的脂质体凝胶酞菁制剂由一组卵磷脂脂质体制成,所述卵磷脂脂质体掺入了疏水性活性剂,所述疏水性活性剂选自羟基铝,铝,锌,硅或有机硅酸盐或无疏水性金属酞菁与圆形药房凝胶以10:1:1的比例:10混合。可以通过用葡萄糖或其他糖,聚乙二醇或其他聚合物,卵磷脂或NaCl或其他适用于药理的盐包被来处理添加的活性成分。制备方法是,在适当的室内,在微流化器中将浓度为每毫升液体1至40毫克的卵磷脂在大于0摄氏度的温度和50摄氏度的压力下流化至最终粒径小于1000纳米。 200 MPa,然后连续混合,相对于卵磷脂以5:1到0.1:1的比例添加活性成分或处理过的活性成分,所得悬浮液在各自较小腔室的微流化器上反复流化至最终在大于0℃的温度下,在100至200MPa的压力下,如果粒径小于500纳米,则将得到的悬浮液与循环的药物凝胶以10∶1至1∶10的比例混合。任选地,在上述第一步中,卵磷脂分别被流化,而活性剂也被分别流化,或者卵磷脂通过50-100nm的过滤器挤出而被处理。然后将所得的悬浮液与循环的药物凝胶以10:1至1:10的比例混合。将得到的含脂质体的凝胶与掺入的活性成分一起用于皮肤科的局部肿瘤或治疗中可用于光导光导的其他肿瘤。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号